Boehringer Ingelheim

Boehringer Ingelheim Signs Option to Acquire Immunology Partner, Trutino Biosciences
BioSpace
Wed, 06/15/22 - 10:56 am
Boehringer Ingelheim
Trutino Biosciences
M&A
cancer
ASCO 2022 – the spirit of Rova-T struggles to live on
EP Vantage
Tue, 06/7/22 - 10:19 am
ASCO 2022
Rova-T
AbbVie
Harpoon Therapeutics
Amgen
Boehringer Ingelheim
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
Endpoints
Fri, 06/3/22 - 10:54 am
Boehringer Ingelheim
oncology
cancer
Singapore
R&D
Boehringer OKs $100M biobucks deal for hearing loss R&D project
Fierce Biotech
Wed, 04/13/22 - 10:38 am
Boehringer Ingelheim
hearing loss
Autigen
biobucks
Boehringer Ingelheim boosts R&D commitment, promises up to 15 new product launches by 2025
Endpoints
Tue, 04/5/22 - 11:31 pm
Boehringer Ingelheim
R&D
Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results
BioSpace
Wed, 03/16/22 - 11:20 pm
Eli Lilly
Boehringer Ingelheim
clinical trials
chronic kidney disease
empagliflozin
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
Europe
AstraZeneca
Farxiga
Boehringer backs AI-powered anti-infective startup ArrePath
Pharmaforum
Mon, 03/7/22 - 09:57 am
Boehringer Ingelheim
machine learning
artificial intelligence
ArrePath
anti-infectives
funding
Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label
Fierce Pharma
Fri, 02/25/22 - 10:24 am
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
FDA
Boehringer secures FDA’s Breakthrough Therapy Designation for oral therapy
Pharmaceutical Business Review
Fri, 02/25/22 - 09:58 am
Boehringer Ingelheim
idiopathic pulmonary fibrosis
FDA
BI 1015550
breakthrough status
Boehringer’s spesolimab data raises hope for serious skin disease
Pharmaforum
Sun, 12/26/21 - 11:14 pm
Boehringer Ingelheim
spesolimab
clinical trials
generalized pustular psoriasis
Boehringer invests again in AI diagnosis specialist Brainomix
Pharmaforum
Thu, 12/16/21 - 10:51 am
Boehringer Ingelheim
Brainomix
digital health
artificial intelligence
Medical Imaging
Boehringer-Lilly’s Jardiance obtains FDA priority review to treat heart failure
Pharmaceutical Business Review
Fri, 11/12/21 - 10:37 am
Eli Lilly
Boehringer Ingelheim
Jardiance
priority review
FDA
heart failure
Boehringer Ingelheim Steps Up to the Plate for Cystic Fibrosis Patients
BioSpace
Tue, 10/19/21 - 10:59 pm
Boehringer Ingelheim
cystic fibrosis
BI 3720931
Oxford BioMedica
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Boehringer Ingelheim
Humira
biosimilars
interchangeable biosimilars
Cyltezo
AbbVie
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Boehringer Ingelheim
AbbVie
Humira
interchangeable biosimilars
biosimilars
Cyltezo
FDA
Boehringer Ingelheim inaugurates Vienna production facility
Biopharma Reporter
Thu, 10/14/21 - 11:14 pm
Boehringer Ingelheim
Austria
drug manufactruing
Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections
Fierce Pharma
Tue, 10/12/21 - 11:41 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
gamification
Boehringer Ingelheim inaugurates Vienna production facility
Biopharma Reporter
Mon, 10/11/21 - 10:10 am
Boehringer Ingelheim
Austria
drug manufacturing
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules
Fierce Pharma
Fri, 10/8/21 - 11:00 am
GSK
Sanofi
Pfizer
Boehringer Ingelheim
legal
class action lawsuits
Zantac

Pages